強生(Johnson & Johnson)公(gong)布2022年(nian)第三季度財務(wu)(wu)業績。季度營收(shou)同(tong)(tong)(tong)比(bi)(bi)增(zeng)長(chang)(chang)1.9%至237.91億(yi)美(mei)(mei)元(yuan)。凈利(li)潤(run)為44.58億(yi)美(mei)(mei)元(yuan)，同(tong)(tong)(tong)比(bi)(bi)增(zeng)長(chang)(chang)21.6%。經調整的凈利(li)潤(run)為67.79億(yi)美(mei)(mei)元(yuan)，同(tong)(tong)(tong)比(bi)(bi)下(xia)降(jiang)2.7%。按地區劃(hua)分，美(mei)(mei)國(guo)(guo)銷(xiao)售(shou)(shou)額為124.53億(yi)美(mei)(mei)元(yuan)，同(tong)(tong)(tong)比(bi)(bi)增(zeng)長(chang)(chang)4.1%。國(guo)(guo)際銷(xiao)售(shou)(shou)額為113.38億(yi)美(mei)(mei)元(yuan)，同(tong)(tong)(tong)比(bi)(bi)下(xia)降(jiang)0.3%。按業務(wu)(wu)劃(hua)分，消費(fei)者健康業務(wu)(wu)銷(xiao)售(shou)(shou)額37.95億(yi)美(mei)(mei)元(yuan)，同(tong)(tong)(tong)比(bi)(bi)下(xia)降(jiang)0.4%。制藥業務(wu)(wu)銷(xiao)售(shou)(shou)額132.14億(yi)美(mei)(mei)元(yuan)，同(tong)(tong)(tong)比(bi)(bi)增(zeng)長(chang)(chang)2.6%。醫療技(ji)術業務(wu)(wu)銷(xiao)售(shou)(shou)額67.82億(yi)美(mei)(mei)元(yuan)，同(tong)(tong)(tong)比(bi)(bi)增(zeng)長(chang)(chang)2.1%。(全(quan)球企業動態)